Abstract
Objective: Serous tubal intraepithelial carcinoma (STIC) is considered the precursor of many ovarian and primary peritoneal serous carcinomas in BRCA mutation-positive women. STIC are discovered incidentally in the fallopian tubes via risk-reducing salpingo-oophorectomy in approximately 5%–7% of women. Unfortunately, the biological and clinical relevance of these lesions in BRCA mutation-positive women is unknown. The purpose of this study was to review the incidence of STIC lesions in women undergoing risk-reducing salpingo-oophorectomy with a BRCA mutation compared to those without a mutation and their outcomes in follow-up.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
